Intramyocardial hemorrhage

Last revised by Joachim Feger on 28 Nov 2021

Intramyocardial hemorrhage is referred to as the extravasation of erythrocytes and/or blood products into the myocardium.

Intramyocardial hemorrhage occurs in 35-50% of the patients with successful coronary revascularization of ST-elevation myocardial infarction 1-4.

Intramyocardial hemorrhage is characterized by erythrocytes and blood products within the myocardium or rather within the myocardial extracellular space. In the setting of myocardial infarction and reperfusion, it is strongly associated with the occurrence of late microvascular obstruction (MVO) 1-4.

The immediate cause is vascular endothelial damage secondary to the following 1-6

  • reperfusion injury
  • cardiac trauma

Intramyocardial hemorrhage has been diagnosed in the setting of a hypointense zone surrounded by myocardial edema in T2-weighted and/or STIR images 3Hemoglobin and its degradation products are known for their paramagnetic effect and thus influence MR relaxation times 1.

  • T2/STIR: hypointense
  • T2* mapping: two cut off values: T2* < 20 [ms] or 2 standard deviations below the mean 3
  • T2 mapping: decreased T2 [ms] *
  • T1 mapping: decreased T1 [ms] *
  • IRGRE/PSIR: hypointense zone within an infarct zone of late gadolinium enhancement, indistinguishable from microvascular obstruction

* sensitivity of T2 mapping and T1 mapping is impaired in an acute setting because of the presence of myocardial edema

Intramyocardial hemorrhage is a source of residual myocardial iron, which is thought to cause prolonged inflammation and thus adverse remodeling, associated with a poorer prognosis or major adverse cardiovascular events (MACE).

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.